Cell Therapy Focused on Age-Related Conditions
GeriGene is dedicated to increasing the quality of life during healthy years and enhancing health and life quality during aging.
The company's research, development and commercialization of products and services leverage the cellular and genetic pathways controlling the aging process.
The result is a series of products for first-stage targets that address needs poorly addressed by current technology. These therapies are in the clinical development stage.
GeriGene is a genetic and cellular biomedical company. Its long-term mission is to enhance the human natural life span and to address emerging issues in healthcare.
GeriGene is ideally positioned to transform the therapeutics associated with many aspects of human aging and disease. Our focus is on the intersection of two fundamental questions: What is the nature of the aging process? And what factors trigger age-associated disease?